Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Ravdin

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The American Journal of the Medical Sciences|February 1, 1994
Case report: use of insulin-like growth factor-I gene expression to distinguish between breast and ovarian cancerD Yee, J G Jackson, D D Von Hoff, et al.
Cell Motility and the Cytoskeleton|May 15, 1998
Preparation of a monoclonal antibody specific for the class I isotype of beta-tubulin: the beta isotypes of tubulin differ in their cellular distributions within human tissuesM C Roach, V L Boucher, C Walss, et al.
Breast Cancer Research and Treatment|January 1, 1994
Prognostic factors: rationale and methods of analysis and integrationG M Clark, S G Hilsenbeck, P M Ravdin, et al.
Journal of Biological Response Modifiers|February 1, 1990
Interferon-alpha-n1 and continuous infusion vinblastine for treatment of advanced renal cell carcinomaD L Trump, P M Ravdin, E C Borden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patientsM De Laurentiis, S De Placido, A R Bianco, et al.
Cytometry|January 1, 1993
Neural Network Analysis of DNA flow cytometry histogramsP M Ravdin, G M Clark, J J Hough, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancerC K Osborne, M C Sunderland, J A Neidhart, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Treatment decisions in axillary node-negative breast cancer patientsW L McGuire, A K Tandon, D C Allred, et al.
Cancer|September 15, 1992
Prognosis and treatment decisions in patients with breast cancer without axillary node involvementW L McGuire, A K Tandon, D C Allred, et al.
Cancer Letters|June 24, 1997
Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patientsP M Ravdin, C A de Moor, S G Hilsenbeck, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The American Journal of the Medical Sciences|February 1, 1994
Case report: use of insulin-like growth factor-I gene expression to distinguish between breast and ovarian cancerD Yee, J G Jackson, D D Von Hoff, et al.
Cell Motility and the Cytoskeleton|May 15, 1998
Preparation of a monoclonal antibody specific for the class I isotype of beta-tubulin: the beta isotypes of tubulin differ in their cellular distributions within human tissuesM C Roach, V L Boucher, C Walss, et al.
Breast Cancer Research and Treatment|January 1, 1994
Prognostic factors: rationale and methods of analysis and integrationG M Clark, S G Hilsenbeck, P M Ravdin, et al.
Journal of Biological Response Modifiers|February 1, 1990
Interferon-alpha-n1 and continuous infusion vinblastine for treatment of advanced renal cell carcinomaD L Trump, P M Ravdin, E C Borden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patientsM De Laurentiis, S De Placido, A R Bianco, et al.
Cytometry|January 1, 1993
Neural Network Analysis of DNA flow cytometry histogramsP M Ravdin, G M Clark, J J Hough, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancerC K Osborne, M C Sunderland, J A Neidhart, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Treatment decisions in axillary node-negative breast cancer patientsW L McGuire, A K Tandon, D C Allred, et al.
Cancer|September 15, 1992
Prognosis and treatment decisions in patients with breast cancer without axillary node involvementW L McGuire, A K Tandon, D C Allred, et al.
Cancer Letters|June 24, 1997
Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patientsP M Ravdin, C A de Moor, S G Hilsenbeck, et al.
Pageof 6